APVO is 0.90 around.
Sharks are starting to buy it, also if we broke a long term bear flag.
Investing mentality, some shares in my portfolio and let it run!
More of my trades here on tradingview or:
stocktraderjournal.wordpress.com
APVO is a funny stock in that it rocketed past $4 and subsequently fell just as hard and fast. The fall was never really explained as far as I know. SEC filings have come up fairly recently and are positive.
Median resistance line shows an incubation level that's held. Previous breakout was right up against it. Current levels are holding above it and about to...
APVO had a long period of consolidation, and it seems breaking out now. Moneyflow went up significantly. If it can break above $2.53 it can easily go to $3 area.
* Trade Criteria *
Date First Found- June 21, 2017
Pattern/Why- Fallen angel formation
Entry Target Criteria- Break of $2.53
Exit Target Criteria- $2.88
Stop Loss Criteria- $2.31
Please check...
Aptevo Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, commercialization, and sale of novel oncology and hematology therapeutics to improve patients lives. Its pipeline includes APVO210, APVO436, ROR1 Candidate, and ALG.APV-527. The company was founded on February 22, 2016 and is headquartered in Seattle, WA.
APVO
